Atara Biotherapeutics, Inc.

Home » Atara Biotherapeutics, Inc.

Secondary

Atara Biotherapeutics, Inc.

They are a leading T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.

Symbol

ATRA

Last Closing Price
$19.25

Shares
5,500,000

Effective Date
January 4, 2018

Underwriters
J.P. Morgan, Cowen

To view the prospectus for Atara Biotherapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253